CITRIREX

Medicinal preparations for improving hypoxia; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for the treatment of pulmonary arterial hypertension, angina pectoris, and/or hypoxia; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treatment of the respiratory system; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical products for treating respiratory diseases; Pharmaceuticals for the treatment of erectile dysfunction; Pharmaceuticals, namely, inducers of erections; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of dissolvable tablets, orodispersible tablets, and/or sublingual tablets that facilitate the delivery of pharmaceutical preparations